Prothena Corp. Plc (PRTA)
8.26
-0.14
(-1.67%)
USD |
NASDAQ |
Nov 20, 12:13
Prothena Cash from Operations (Quarterly) : -11.88M for Sept. 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -11.88M |
| June 30, 2026 | -25.06M |
| March 31, 2026 | 28.88M |
| December 31, 2025 | -21.97M |
| September 30, 2025 | -43.26M |
| June 30, 2025 | -50.11M |
| March 31, 2025 | -53.36M |
| December 31, 2024 | -44.59M |
| September 30, 2024 | -46.48M |
| June 30, 2024 | 16.19M |
| March 31, 2024 | -73.05M |
| December 31, 2023 | -49.78M |
| September 30, 2023 | 9.623M |
| June 30, 2023 | -45.59M |
| March 31, 2023 | -47.46M |
| December 31, 2022 | -7.775M |
| September 30, 2022 | -27.03M |
| June 30, 2022 | -33.40M |
| March 31, 2022 | -37.42M |
| December 31, 2021 | -23.66M |
| September 30, 2021 | 110.26M |
| June 30, 2021 | 36.62M |
| March 31, 2021 | -33.67M |
| December 31, 2020 | -20.24M |
| September 30, 2020 | -21.95M |
| Date | Value |
|---|---|
| June 30, 2020 | -18.69M |
| March 31, 2020 | -23.17M |
| December 31, 2019 | -14.36M |
| September 30, 2019 | -8.654M |
| June 30, 2019 | -11.95M |
| March 31, 2019 | -17.44M |
| December 31, 2018 | -20.50M |
| September 30, 2018 | -33.00M |
| June 30, 2018 | 57.73M |
| March 31, 2018 | -31.58M |
| December 31, 2017 | -39.62M |
| September 30, 2017 | -22.16M |
| June 30, 2017 | -37.31M |
| March 31, 2017 | -37.84M |
| December 31, 2016 | -30.75M |
| September 30, 2016 | -30.19M |
| June 30, 2016 | -28.16M |
| March 31, 2016 | -25.15M |
| December 31, 2015 | -19.38M |
| September 30, 2015 | -16.61M |
| June 30, 2015 | -10.93M |
| March 31, 2015 | -14.72M |
| December 31, 2014 | -12.21M |
| September 30, 2014 | -12.55M |
| June 30, 2014 | 6.220M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Alkermes Plc | 93.48M |
| Amarin Corp. Plc | 9.218M |
| Agenus, Inc. | -20.10M |
| Amgen, Inc. | 4.241B |
| Anika Therapeutics, Inc. | 8.377M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.0686M |
| Cash from Financing (Quarterly) | -4.615M |
| Free Cash Flow | -30.75M |
| Free Cash Flow Per Share (Quarterly) | -0.2322 |
| Free Cash Flow to Equity (Quarterly) | -11.21M |
| Free Cash Flow to Firm (Quarterly) | -11.95M |
| Free Cash Flow Yield | -7.25% |